Partnership · R&D and distribution
The first whole-genome prostate cancer test from seminal fluid
MIDWINTER × GENEMBRYOMICS
Midwinter and GenEmbryomics have entered a strategic R&D and distribution partnership to develop the first whole-genome prostate cancer test from seminal fluid, combining Midwinter’s at-home collection and computational analysis with GenEmbryomics’ whole genome sequencing.